Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]

DUAVEE is the first and only therapy to pair conjugated estrogens with an estrogen agonist/antagonist, also known as a selective estrogen receptor modulator (SERM) [2] NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE), a leader in the ... Biopharmaceuticals, FDAPfizer, DUAVEE, conjugated estrogens, menopause
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news